clopidogrel has been researched along with apyrase in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, HV; Benedict, CR; Buja, LM; Campbell, WB; Cui, K; Maffrand, JP; McNatt, J; Ober, JC; Rosolowsky, M; Yao, SK | 1 |
| Reimann, S; Schrör, K; Weber, AA | 1 |
| Dewit, LG; Stewart, FA; te Poele, JA; van der Wal, AF; van Kleef, EM | 1 |
| Klein, N; Koksch, M; Neugebauer, A; Pfeiffer, D; Roethig, G; Rother, T; Seyfarth, HJ | 1 |
| Antonino, MJ; Bliden, KP; Gurbel, PA; Mahla, E; Tantry, US | 1 |
| Broekman, MJ; Fung, CY; Mahaut-Smith, MP; Marcus, AJ | 1 |
| Lecka, J; Rana, MS; Sévigny, J | 1 |
| Kitami, A; Kojima, S; Nishimaki, N; Tsukimoto, M | 1 |
| Abendschein, D; Broekman, MJ; Chen, R; Drosopoulos, JH; Jeong, SS; Marcus, AJ; Moeckel, D; Nguyen, A; Robson, SC; Sun, X | 1 |
| Eichelberger, B; Fedrizzi, S; Gremmel, T; Panzer, S; Weigel, G | 1 |
1 review(s) available for clopidogrel and apyrase
| Article | Year |
|---|---|
P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window.
Topics: Adenosine Triphosphate; Antigens, CD; Apyrase; Aspirin; Biomedical Research; Cardiovascular Diseases; Cerebral Hemorrhage; Clinical Trials as Topic; Clopidogrel; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Endothelium, Vascular; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Outcome | 2009 |
9 other study(ies) available for clopidogrel and apyrase
| Article | Year |
|---|---|
ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Topics: Adenosine Diphosphate; Animals; Apyrase; Bridged Bicyclo Compounds, Heterocyclic; Clopidogrel; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Hydrazines; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin; Thromboxane A2; Ticlopidine | 1992 |
Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Topics: Adenosine Diphosphate; Alprostadil; Apyrase; Blood Platelets; Clopidogrel; Cyclic AMP; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Serum Albumin; Stereoisomerism; Ticlopidine; Time Factors | 1999 |
Radiation-induced glomerular thrombus formation and nephropathy are not prevented by the ADP receptor antagonist clopidogrel.
Topics: Animals; Apyrase; Clopidogrel; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Edetic Acid; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Glomerular Filtration Rate; Image Processing, Computer-Assisted; Kidney Function Tests; Kidney Glomerulus; Mice; Mice, Inbred C3H; Mice, Nude; Purinergic P2 Receptor Antagonists; Radiation Injuries, Experimental; Radiation Tolerance; Thrombosis; Ticlopidine | 2001 |
Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Apyrase; Blood Platelets; Clopidogrel; Female; Humans; Male; Middle Aged; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Thrombosis; Ticlopidine | 2002 |
Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Apyrase; Blood Platelets; Clopidogrel; Female; Flow Cytometry; Humans; Inflammation; Male; Middle Aged; Myocardial Ischemia; P-Selectin; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine | 2009 |
Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Antigens, CD; Apyrase; Chlorocebus aethiops; Clopidogrel; COS Cells; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Hydrolysis; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Rats; Species Specificity; Ticlopidine; Umbilical Veins | 2010 |
Autocrine regulation of γ-irradiation-induced DNA damage response via extracellular nucleotides-mediated activation of P2Y6 and P2Y12 receptors.
Topics: Adenosine Triphosphate; Apyrase; Ataxia Telangiectasia Mutated Proteins; Autocrine Communication; Cell Cycle Proteins; Cell Line, Tumor; Clopidogrel; DNA Damage; DNA Repair; DNA-Binding Proteins; Extracellular Space; Gamma Rays; Histones; Humans; Intracellular Signaling Peptides and Proteins; Isothiocyanates; Protein Serine-Threonine Kinases; Pyridines; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Receptors, Purinergic P2Y12; Tetrazoles; Thiourea; Ticlopidine; Tumor Suppressor p53-Binding Protein 1; Tumor Suppressor Proteins | 2012 |
Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk.
Topics: Adenosine Diphosphate; Animals; Apyrase; Clopidogrel; Coronary Circulation; Dogs; Fibrinolysis; Hemorrhage; Humans; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Piperazines; Platelet Aggregation; Prasugrel Hydrochloride; Risk Factors; Thiophenes; Thrombosis; Ticlopidine; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Vascular Patency | 2014 |
Underlying mechanism and specific prevention of hemolysis-induced platelet activation.
Topics: Adenosine Diphosphate; Adult; Aged; Apyrase; Blood Group Incompatibility; Blood Platelets; Clopidogrel; Female; Hemolysis; Humans; Male; Middle Aged; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Purinergic P2Y12; Ticlopidine | 2017 |